JP2008539187A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008539187A5 JP2008539187A5 JP2008508169A JP2008508169A JP2008539187A5 JP 2008539187 A5 JP2008539187 A5 JP 2008539187A5 JP 2008508169 A JP2008508169 A JP 2008508169A JP 2008508169 A JP2008508169 A JP 2008508169A JP 2008539187 A5 JP2008539187 A5 JP 2008539187A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- mycobacterium
- mtb72f
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67654905P | 2005-04-29 | 2005-04-29 | |
| US60/676,549 | 2005-04-29 | ||
| US77701706P | 2006-02-27 | 2006-02-27 | |
| US60/777,017 | 2006-02-27 | ||
| PCT/EP2006/004319 WO2006117240A2 (en) | 2005-04-29 | 2006-04-27 | Novel method for preventing or treating m tuberculosis infection |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011207361A Division JP2012065650A (ja) | 2005-04-29 | 2011-09-22 | 結核菌感染の予防または治療のための新規方法 |
| JP2012227192A Division JP5659207B2 (ja) | 2005-04-29 | 2012-10-12 | 結核菌感染の予防または治療のための新規方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008539187A JP2008539187A (ja) | 2008-11-13 |
| JP2008539187A5 true JP2008539187A5 (enExample) | 2009-06-18 |
| JP5164830B2 JP5164830B2 (ja) | 2013-03-21 |
Family
ID=36972897
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008508169A Expired - Fee Related JP5164830B2 (ja) | 2005-04-29 | 2006-04-27 | 結核菌感染の予防または治療のための新規方法 |
| JP2011207361A Pending JP2012065650A (ja) | 2005-04-29 | 2011-09-22 | 結核菌感染の予防または治療のための新規方法 |
| JP2012227192A Expired - Fee Related JP5659207B2 (ja) | 2005-04-29 | 2012-10-12 | 結核菌感染の予防または治療のための新規方法 |
| JP2014217282A Pending JP2015057403A (ja) | 2005-04-29 | 2014-10-24 | 結核菌感染の予防または治療のための新規方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011207361A Pending JP2012065650A (ja) | 2005-04-29 | 2011-09-22 | 結核菌感染の予防または治療のための新規方法 |
| JP2012227192A Expired - Fee Related JP5659207B2 (ja) | 2005-04-29 | 2012-10-12 | 結核菌感染の予防または治療のための新規方法 |
| JP2014217282A Pending JP2015057403A (ja) | 2005-04-29 | 2014-10-24 | 結核菌感染の予防または治療のための新規方法 |
Country Status (24)
| Country | Link |
|---|---|
| US (6) | US8470338B2 (enExample) |
| EP (3) | EP2426141B1 (enExample) |
| JP (4) | JP5164830B2 (enExample) |
| KR (4) | KR20130110233A (enExample) |
| CN (3) | CN102617739A (enExample) |
| AT (1) | ATE543832T1 (enExample) |
| AU (1) | AU2006243357B2 (enExample) |
| BR (1) | BRPI0611347A2 (enExample) |
| CA (2) | CA2821389C (enExample) |
| CY (1) | CY1112851T1 (enExample) |
| DK (3) | DK1877426T3 (enExample) |
| EA (1) | EA012576B1 (enExample) |
| ES (3) | ES2524570T3 (enExample) |
| HR (3) | HRP20120331T1 (enExample) |
| IL (2) | IL186654A (enExample) |
| MA (1) | MA29678B1 (enExample) |
| NO (3) | NO340766B1 (enExample) |
| NZ (1) | NZ562729A (enExample) |
| PH (1) | PH12013502449A1 (enExample) |
| PL (3) | PL2426141T3 (enExample) |
| PT (3) | PT2426141E (enExample) |
| SI (3) | SI2457926T1 (enExample) |
| WO (1) | WO2006117240A2 (enExample) |
| ZA (1) | ZA200709209B (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20130110233A (ko) * | 2005-04-29 | 2013-10-08 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 결핵균 감염을 예방 또는 치료하기 위한 신규한 방법 |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| CA2649688A1 (en) * | 2006-03-14 | 2007-09-20 | Oregon Health & Science University | Methods for detecting a mycobacterium tuberculosis infection |
| US9717788B2 (en) | 2007-03-02 | 2017-08-01 | Glaxosmithkline Biologicals Sa | Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant |
| HUE031411T2 (en) | 2007-03-02 | 2017-07-28 | Glaxosmithkline Biologicals Sa | New Methods and Preparations |
| WO2009025820A2 (en) * | 2007-08-21 | 2009-02-26 | Stc. Unm | Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution |
| US20110189217A1 (en) * | 2008-06-26 | 2011-08-04 | Barry Michael A | Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance |
| LT2315597T (lt) * | 2008-07-25 | 2018-02-12 | Glaxosmithkline Biologicals S.A. | Naujos kompozicijos ir būdai |
| PT2315834T (pt) | 2008-07-25 | 2018-08-10 | Glaxosmithkline Biologicals Sa | A proteína rv2386c de tuberculose, composições e as suas utilizações |
| SI2315773T1 (sl) | 2008-07-25 | 2016-12-30 | Glaxosmithkline Biologicals S.A. | Polipeptidi, polinukleotidi in sestavki za uporabo pri zdravljenju latentne tuberkuloze |
| GB0815872D0 (en) | 2008-09-01 | 2008-10-08 | Pasteur Institut | Novel method and compositions |
| TR201903223T4 (tr) | 2009-04-24 | 2019-03-21 | Statens Seruminstitut | Reaktivasyonu önlemek üzere bir tüberküloz TB aşısı. |
| HRP20161608T1 (hr) | 2010-01-27 | 2017-01-13 | Glaxosmithkline Biologicals Sa | Modificirani tuberkulozni antigeni |
| CA2819297A1 (en) * | 2010-12-14 | 2012-06-21 | Glaxosmithkline Biologicals S.A. | Mycobacterium antigenic composition |
| GB201022007D0 (en) | 2010-12-24 | 2011-02-02 | Imp Innovations Ltd | DNA-sensor |
| ES2631556T3 (es) * | 2011-01-04 | 2017-09-01 | Archivel Farma, Sl | Formulación de liposomas adecuada para tratar o prevenir la tuberculosis |
| GB201116248D0 (en) | 2011-09-20 | 2011-11-02 | Glaxosmithkline Biolog Sa | Liposome production using isopropanol |
| WO2013090897A1 (en) * | 2011-12-15 | 2013-06-20 | The Trustees Of The University Of Pennsylvania | Using adaptive immunity to detect drug resistance |
| PL2802345T3 (pl) | 2012-01-12 | 2018-08-31 | Archivel Farma, S.L. | Szczepionka mtb-c przeciw reakcjom alergicznym |
| PT2879701T (pt) * | 2012-08-03 | 2024-02-12 | Access To Advanced Health Inst | Composições e métodos para o tratamento de uma infeção ativa por mycobacterium tuberculosis |
| CN104685054A (zh) * | 2012-09-27 | 2015-06-03 | 成都永安制药有限公司 | Lsr2活性降低或敲除的改良BCG菌株及包含该菌株的药物组合物 |
| CN102994595B (zh) * | 2012-11-30 | 2018-10-26 | 广州白云山拜迪生物医药有限公司 | 一种融合蛋白包涵体的制备方法 |
| CN102993266B (zh) * | 2012-11-30 | 2019-08-23 | 广州白云山拜迪生物医药有限公司 | 一种融合蛋白的纯化和复性方法 |
| GB201405921D0 (en) * | 2014-04-02 | 2014-05-14 | Glaxosmithkline Biolog Sa | Novel methods for inducing an immune response |
| US10588980B2 (en) * | 2014-06-23 | 2020-03-17 | Novartis Ag | Fatty acids and their use in conjugation to biomolecules |
| US10335374B2 (en) | 2014-12-04 | 2019-07-02 | University System of Georgia, Valdosta State University | Tablet composition for anti-tuberculosis antibiotics |
| EP3278087A4 (en) * | 2015-04-02 | 2018-12-19 | Biodesy, Inc. | Methods for determining protein structure using a surface-selective nonlinear optical technique |
| WO2016179231A1 (en) * | 2015-05-04 | 2016-11-10 | Board Of Trustees Of Michigan State University | Compositions and methods for inhibiting bacterial growth |
| GB201513176D0 (en) * | 2015-07-27 | 2015-09-09 | Glaxosmithkline Biolog Sa | Novel methods for inducing an immune response |
| CA3045952A1 (en) | 2016-12-07 | 2018-06-14 | Glaxosmithkline Biologicals Sa | Novel process |
| US11717519B2 (en) | 2017-04-21 | 2023-08-08 | Washington University In St. Louis | Use of fatty acid oxidation inhibitors as antimicrobials |
| WO2019178472A1 (en) * | 2018-03-16 | 2019-09-19 | Washington University In St. Louis | Use of fatty acid oxidation inhibitors as antimicrobials |
| GB201707700D0 (en) | 2017-05-12 | 2017-06-28 | Glaxosmithkline Biologicals Sa | Dried composition |
| TW202237116A (zh) * | 2020-12-02 | 2022-10-01 | 日商塩野義製藥股份有限公司 | 以組合細胞色素bc1抑制劑與克拉黴素或阿奇黴素為特徵之用於治療分枝桿菌感染之藥物 |
| CA3226978A1 (en) | 2021-08-31 | 2023-03-09 | Vir Biotechnology, Inc. | Tuberculosis vaccines |
| KR102534846B1 (ko) | 2021-12-14 | 2023-05-19 | 재단법인 환동해산업연구원 | 결핵균에 항균 활성을 가지는 해조류 추출물 |
| CN116162141B (zh) * | 2022-11-30 | 2024-04-12 | 中国疾病预防控制中心传染病预防控制所 | 一种结核分枝杆菌抗原epcra013及其应用 |
Family Cites Families (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235877A (en) | 1979-06-27 | 1980-11-25 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
| US4769330A (en) | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
| US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| US4866034A (en) | 1982-05-26 | 1989-09-12 | Ribi Immunochem Research Inc. | Refined detoxified endotoxin |
| US4436727A (en) | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| GB8508845D0 (en) | 1985-04-04 | 1985-05-09 | Hoffmann La Roche | Vaccinia dna |
| US4777127A (en) | 1985-09-30 | 1988-10-11 | Labsystems Oy | Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US4877611A (en) | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US6024983A (en) | 1986-10-24 | 2000-02-15 | Southern Research Institute | Composition for delivering bioactive agents for immune response and its preparation |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| GB8702816D0 (en) | 1987-02-07 | 1987-03-11 | Al Sumidaie A M K | Obtaining retrovirus-containing fraction |
| CA1340522C (en) | 1987-03-10 | 1999-05-04 | Heinz Dobeli | Fusion proteins containing neighbouring histidines for improved purification |
| CA1331443C (en) | 1987-05-29 | 1994-08-16 | Charlotte A. Kensil | Saponin adjuvant |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
| WO1989001973A2 (en) | 1987-09-02 | 1989-03-09 | Applied Biotechnology, Inc. | Recombinant pox virus for immunization against tumor-associated antigens |
| AU2613988A (en) | 1988-01-04 | 1989-08-01 | E.I. Du Pont De Nemours And Company | Multiple stage affinity process for isolation of specific cells from a cell mixture |
| US5215926A (en) | 1988-06-03 | 1993-06-01 | Cellpro, Inc. | Procedure for designing efficient affinity cell separation processes |
| AP129A (en) | 1988-06-03 | 1991-04-17 | Smithkline Biologicals S A | Expression of retrovirus gag protein eukaryotic cells |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| US5549910A (en) | 1989-03-31 | 1996-08-27 | The Regents Of The University Of California | Preparation of liposome and lipid complex compositions |
| EP0487587A1 (en) | 1989-08-18 | 1992-06-03 | Chiron Corporation | Recombinant retroviruses delivering vector constructs to target cells |
| US5725871A (en) | 1989-08-18 | 1998-03-10 | Danbiosyst Uk Limited | Drug delivery compositions comprising lysophosphoglycerolipid |
| KR920007887B1 (ko) | 1989-08-29 | 1992-09-18 | 스즈키 지도오샤 고오교오 가부시키가이샤 | 내연기관의 배기가스 정화장치 |
| US5707644A (en) | 1989-11-04 | 1998-01-13 | Danbiosyst Uk Limited | Small particle compositions for intranasal drug delivery |
| US5466468A (en) | 1990-04-03 | 1995-11-14 | Ciba-Geigy Corporation | Parenterally administrable liposome formulation comprising synthetic lipids |
| WO1991016116A1 (en) | 1990-04-23 | 1991-10-31 | Cellpro Incorporated | Immunoselection device and method |
| SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
| JP3218637B2 (ja) | 1990-07-26 | 2001-10-15 | 大正製薬株式会社 | 安定なリポソーム水懸濁液 |
| EP0468520A3 (en) | 1990-07-27 | 1992-07-01 | Mitsui Toatsu Chemicals, Inc. | Immunostimulatory remedies containing palindromic dna sequences |
| JP2958076B2 (ja) | 1990-08-27 | 1999-10-06 | 株式会社ビタミン研究所 | 遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法 |
| ATE154698T1 (de) | 1990-10-18 | 1997-07-15 | Cellpro Inc | Vorrichtung und verfahren zur trennung von partikeln mittels eines biegsamen gefässes |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| DK0598816T3 (da) | 1991-08-15 | 1999-11-22 | Deutsches Krebsforsch | Osp A-proteiner fra Borrelia Burgdorferi-undergrupper, hvilke proteiner koder for gener og vacciner |
| US5240856A (en) | 1991-10-23 | 1993-08-31 | Cellpro Incorporated | Apparatus for cell separation |
| US5756353A (en) | 1991-12-17 | 1998-05-26 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol-and liposome-based delivery |
| ES2105262T3 (es) | 1992-05-18 | 1997-10-16 | Minnesota Mining & Mfg | Dispositivo de suministro de farmaco a traves de las mucosas. |
| US5792451A (en) | 1994-03-02 | 1998-08-11 | Emisphere Technologies, Inc. | Oral drug delivery compositions and methods |
| NZ253137A (en) | 1992-06-25 | 1996-08-27 | Smithkline Beecham Biolog | Vaccine comprising antigen and/or antigenic composition, qs21 (quillaja saponaria molina extract) and 3 de-o-acylated monophosphoryl lipid a. |
| JPH08505625A (ja) | 1993-01-11 | 1996-06-18 | ダナ−ファーバー キャンサー インスティチュート | 細胞毒性ｔリンパ球応答の誘導 |
| FR2702160B1 (fr) | 1993-03-02 | 1995-06-02 | Biovecteurs As | Vecteurs particulaires synthétiques et procédé de préparation. |
| EP0689454B2 (en) | 1993-03-23 | 2005-02-23 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| FR2704145B1 (fr) | 1993-04-21 | 1995-07-21 | Pasteur Institut | Vecteur particulaire et composition pharmaceutique le contenant. |
| US5955077A (en) | 1993-07-02 | 1999-09-21 | Statens Seruminstitut | Tuberculosis vaccine |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| US5741516A (en) | 1994-06-20 | 1998-04-21 | Inex Pharmaceuticals Corporation | Sphingosomes for enhanced drug delivery |
| US5551622A (en) | 1994-07-13 | 1996-09-03 | Yoon; Inbae | Surgical stapler |
| DE69535905D1 (de) | 1994-07-15 | 2009-02-26 | Coley Pharm Group Inc | Immunomodulatorische Oligonukleotide |
| FR2723849B1 (fr) | 1994-08-31 | 1997-04-11 | Biovector Therapeutics Sa | Procede pour augmenter l'immunogenicite, produit obtenu et composition pharmaceutique |
| AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
| US5795587A (en) | 1995-01-23 | 1998-08-18 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
| US5580579A (en) | 1995-02-15 | 1996-12-03 | Nano Systems L.L.C. | Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers |
| IE80468B1 (en) | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| JPH11506332A (ja) | 1995-06-02 | 1999-06-08 | インサイト・ファーマスーティカルズ・インコーポレイテッド | 全長ｃＤＮＡ配列を獲得する改良された方法 |
| US5738868A (en) | 1995-07-18 | 1998-04-14 | Lipogenics Ltd. | Liposome compositions and kits therefor |
| WO1997009429A2 (en) | 1995-09-01 | 1997-03-13 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
| ES2271449T3 (es) | 1995-09-01 | 2007-04-16 | Corixa Corporation | Compuestos para inmunoterapia y diagnostico de la tuberculosis. |
| US6290969B1 (en) | 1995-09-01 | 2001-09-18 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| JP2002515734A (ja) | 1996-01-02 | 2002-05-28 | カイロン コーポレイション | 遺伝子改変された樹状細胞により媒介される免疫刺激 |
| US5856462A (en) | 1996-09-10 | 1999-01-05 | Hybridon Incorporated | Oligonucleotides having modified CpG dinucleosides |
| AU4750597A (en) | 1996-10-11 | 1998-05-11 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
| EP0930893B1 (en) | 1996-10-11 | 2005-04-13 | The Regents of The University of California | Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| US5655998A (en) | 1996-12-03 | 1997-08-12 | Yu; Chih-An | Space walking exerciser |
| PL190237B1 (pl) | 1997-04-01 | 2005-11-30 | Corixa Corp | Kompozycja adiuwantowa, szczepionka, sposób wytwarzania kompozycji adiuwantowej oraz zastosowanie |
| GB9727262D0 (en) | 1997-12-24 | 1998-02-25 | Smithkline Beecham Biolog | Vaccine |
| TR200002284T2 (tr) | 1998-02-05 | 2000-11-21 | Smithkline Beecham Biologicals S.A. | Mage ailesinden tümör ile ilgili tümör türevleri |
| BR9909472A (pt) | 1998-04-07 | 2001-09-11 | Corixa Corp | Polipeptìdeo purificado, processo para prevenir tuberculose, e, composição farmacêutica |
| EP1229931A4 (en) | 1999-10-07 | 2003-05-28 | Corixa Corp | FUSION PROTEINS FROM MYCOBACTERIUM TUBERCULOSIS |
| US7472098B2 (en) | 2000-02-14 | 2008-12-30 | Ubs Financial Services, Inc. | System and method for execution of trades made pursuant to stock option and purchase plans |
| DE60139963D1 (de) * | 2000-06-20 | 2009-10-29 | Corixa Corp | Fusionsproteine aus mycobakterium tuberculosis |
| US20030143240A1 (en) | 2000-06-27 | 2003-07-31 | Cabezon-Silva Teresa Elisa Virginia | Prostase protein vaccine comprising derivatised thiol residues and methods for producing said antigen |
| WO2002072792A2 (en) * | 2001-03-13 | 2002-09-19 | Corixa Corporation | Heterologous fusion protein constructs comprising a leishmania antigen |
| EP1475402B1 (en) | 2002-02-14 | 2009-06-24 | Mitsui Chemicals, Inc. | Polyester resin and catalyst for polyester production, process for producing polyester resin with the catalyst |
| US7026465B2 (en) * | 2002-02-15 | 2006-04-11 | Corixa Corporation | Fusion proteins of Mycobacterium tuberculosis |
| GB0411411D0 (en) | 2004-05-21 | 2004-06-23 | Glaxosmithkline Biolog Sa | Vaccines |
| WO2006078760A1 (en) | 2005-01-19 | 2006-07-27 | Panduit Corp. | Communication channels with suppression cores |
| KR20130110233A (ko) * | 2005-04-29 | 2013-10-08 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 결핵균 감염을 예방 또는 치료하기 위한 신규한 방법 |
| JP4468858B2 (ja) | 2005-06-01 | 2010-05-26 | オリンパスイメージング株式会社 | データ符号化装置、データ符号化方法、プログラム |
| US7296798B2 (en) | 2006-01-31 | 2007-11-20 | Matt Overfield | Gameboard, games played on board and methods of play requiring strategy and luck |
| TR201903223T4 (tr) * | 2009-04-24 | 2019-03-21 | Statens Seruminstitut | Reaktivasyonu önlemek üzere bir tüberküloz TB aşısı. |
| US8567987B2 (en) | 2009-07-21 | 2013-10-29 | Cooper Technologies Company | Interfacing a light emitting diode (LED) module to a heat sink assembly, a light reflector and electrical circuits |
| CA2819297A1 (en) | 2010-12-14 | 2012-06-21 | Glaxosmithkline Biologicals S.A. | Mycobacterium antigenic composition |
| US9119754B2 (en) | 2011-10-08 | 2015-09-01 | Michael Dennis | Mattress overlay system with positionally adjustable, lateral ramp-wedge bolster structure |
| US9051890B2 (en) | 2013-10-28 | 2015-06-09 | Ford Global Technologies, Llc | Method for estimating charge air cooler condensation storage with an intake oxygen sensor |
| US9903268B2 (en) | 2015-04-02 | 2018-02-27 | Ford Global Technologies, Llc | Internal combustion engine with two-stage supercharging capability and with exhaust-gas aftertreatment arrangement, and method for operating an internal combustion engine |
| US9810514B2 (en) | 2015-09-08 | 2017-11-07 | Deufol Sunman Inc. | Ammunition carrier consumer package |
-
2006
- 2006-04-27 KR KR1020137024859A patent/KR20130110233A/ko not_active Ceased
- 2006-04-27 ES ES11190079.1T patent/ES2524570T3/es active Active
- 2006-04-27 BR BRPI0611347-8A patent/BRPI0611347A2/pt active Search and Examination
- 2006-04-27 CN CN2011102974226A patent/CN102617739A/zh active Pending
- 2006-04-27 WO PCT/EP2006/004319 patent/WO2006117240A2/en not_active Ceased
- 2006-04-27 JP JP2008508169A patent/JP5164830B2/ja not_active Expired - Fee Related
- 2006-04-27 DK DK06753523.7T patent/DK1877426T3/da active
- 2006-04-27 NZ NZ562729A patent/NZ562729A/en not_active IP Right Cessation
- 2006-04-27 ES ES11190080.9T patent/ES2524572T3/es active Active
- 2006-04-27 SI SI200631870T patent/SI2457926T1/sl unknown
- 2006-04-27 SI SI200631315T patent/SI1877426T1/sl unknown
- 2006-04-27 KR KR1020077027885A patent/KR101352806B1/ko not_active Expired - Fee Related
- 2006-04-27 AT AT06753523T patent/ATE543832T1/de active
- 2006-04-27 PL PL11190079T patent/PL2426141T3/pl unknown
- 2006-04-27 CN CN201610085598.8A patent/CN106390108B/zh not_active Expired - Fee Related
- 2006-04-27 EP EP11190079.1A patent/EP2426141B1/en not_active Not-in-force
- 2006-04-27 DK DK11190080.9T patent/DK2457926T3/da active
- 2006-04-27 CN CN200680023551.3A patent/CN101273055B/zh not_active Expired - Fee Related
- 2006-04-27 US US11/912,730 patent/US8470338B2/en not_active Expired - Fee Related
- 2006-04-27 PL PL11190080T patent/PL2457926T3/pl unknown
- 2006-04-27 CA CA2821389A patent/CA2821389C/en not_active Expired - Fee Related
- 2006-04-27 DK DK11190079.1T patent/DK2426141T3/da active
- 2006-04-27 ES ES06753523T patent/ES2381492T3/es active Active
- 2006-04-27 KR KR20157004060A patent/KR20150036658A/ko not_active Ceased
- 2006-04-27 EA EA200702081A patent/EA012576B1/ru not_active IP Right Cessation
- 2006-04-27 EP EP06753523A patent/EP1877426B1/en not_active Not-in-force
- 2006-04-27 PT PT111900791T patent/PT2426141E/pt unknown
- 2006-04-27 CA CA2607715A patent/CA2607715C/en not_active Expired - Fee Related
- 2006-04-27 EP EP11190080.9A patent/EP2457926B1/en not_active Not-in-force
- 2006-04-27 HR HRP20120331TT patent/HRP20120331T1/hr unknown
- 2006-04-27 PT PT111900809T patent/PT2457926E/pt unknown
- 2006-04-27 PL PL06753523T patent/PL1877426T3/pl unknown
- 2006-04-27 PT PT06753523T patent/PT1877426E/pt unknown
- 2006-04-27 SI SI200631856T patent/SI2426141T1/sl unknown
- 2006-04-27 KR KR1020127008426A patent/KR20120089475A/ko not_active Ceased
- 2006-04-27 AU AU2006243357A patent/AU2006243357B2/en not_active Ceased
-
2007
- 2007-10-11 NO NO20075201A patent/NO340766B1/no not_active IP Right Cessation
- 2007-10-15 IL IL186654A patent/IL186654A/en not_active IP Right Cessation
- 2007-10-25 MA MA30313A patent/MA29678B1/fr unknown
- 2007-10-25 ZA ZA2007/09209A patent/ZA200709209B/en unknown
-
2011
- 2011-09-13 IL IL215112A patent/IL215112A/en not_active IP Right Cessation
- 2011-09-22 JP JP2011207361A patent/JP2012065650A/ja active Pending
-
2012
- 2012-03-28 NO NO20120381A patent/NO340206B1/no not_active IP Right Cessation
- 2012-04-24 CY CY20121100382T patent/CY1112851T1/el unknown
- 2012-10-12 JP JP2012227192A patent/JP5659207B2/ja not_active Expired - Fee Related
-
2013
- 2013-05-16 US US13/895,574 patent/US9056913B2/en not_active Expired - Fee Related
- 2013-11-26 PH PH12013502449A patent/PH12013502449A1/en unknown
-
2014
- 2014-09-24 NO NO20141158A patent/NO345071B1/no not_active IP Right Cessation
- 2014-10-24 JP JP2014217282A patent/JP2015057403A/ja active Pending
- 2014-11-19 HR HRP20141125TT patent/HRP20141125T1/hr unknown
- 2014-12-08 HR HRP20141184TT patent/HRP20141184T1/hr unknown
-
2015
- 2015-01-23 US US14/603,935 patent/US9655958B2/en not_active Expired - Fee Related
-
2017
- 2017-03-20 US US15/463,557 patent/US10105430B2/en not_active Expired - Fee Related
-
2018
- 2018-09-19 US US16/135,553 patent/US10350283B2/en not_active Expired - Fee Related
-
2019
- 2019-06-25 US US16/451,040 patent/US10639361B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008539187A5 (enExample) | ||
| HRP20120331T1 (hr) | Postupak sprječavanja ili liječenja infekcije bakterijom m. tuberculosis | |
| JP2008543890A5 (enExample) | ||
| Brazier et al. | Towards new TB vaccines | |
| McCluskie et al. | Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA | |
| JP5349070B2 (ja) | Ｐｏｒｐｈｏｒｙｍｏｎａｓｇｉｎｇｉｖａｌｉｓポリペプチドおよびヌクレオチド | |
| JP2021504445A (ja) | エプスタイン−バーウイルスワクチン | |
| JP2013507907A5 (enExample) | ||
| KR101035053B1 (ko) | 감염 잠복기 동안 발현되는 항원을 포함하는 결핵 백신 | |
| JP2008529558A5 (enExample) | ||
| JP2010500399A5 (enExample) | ||
| JP2006512097A5 (enExample) | ||
| JP2012506411A5 (enExample) | ||
| JP2010516290A5 (enExample) | ||
| CN101745104A (zh) | 含有复合佐剂的结核亚单位疫苗 | |
| Plotkin | Six revolutions in vaccinology | |
| EP1446422B1 (fr) | Antigene mycobacterien recombinant de type hemagglutinine de liaison a l'heparine (hbha) methylee | |
| US7935354B2 (en) | Generation of new BCG vaccine strains protecting against the establishment of latent Mycobacterium tuberculosis infection and reactivation from the latent or persistent state | |
| JP2017511327A5 (enExample) | ||
| CN101451145A (zh) | 基于t细胞表位的结核基因疫苗及其制备方法和应用 | |
| CN101455846B (zh) | 脱乙酰壳聚糖递送系统组装的结核基因疫苗及其制备和应用 | |
| Xiao-wen et al. | Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HBsAg by protein boosting | |
| CN116406286A (zh) | 免疫调节化合物及其用于治疗和/或预防传染性疾病的用途 | |
| Karunakaran et al. | Immunoproteomic discovery of Mycobacterium bovis antigens, including the surface lipoprotein Mpt83 as a T cell antigen useful for vaccine development | |
| US9119803B2 (en) | Carious tooth vaccine and preparation method |